IBDEI0VZ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14235,1,4,0)
 ;;=4^G43.919
 ;;^UTILITY(U,$J,358.3,14235,2)
 ;;=^5003911
 ;;^UTILITY(U,$J,358.3,14236,0)
 ;;=G43.901^^83^822^91
 ;;^UTILITY(U,$J,358.3,14236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14236,1,3,0)
 ;;=3^Migraine,Not Intractable w/ Status Migrainosis,Unspec
 ;;^UTILITY(U,$J,358.3,14236,1,4,0)
 ;;=4^G43.901
 ;;^UTILITY(U,$J,358.3,14236,2)
 ;;=^5003908
 ;;^UTILITY(U,$J,358.3,14237,0)
 ;;=G43.909^^83^822^92
 ;;^UTILITY(U,$J,358.3,14237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14237,1,3,0)
 ;;=3^Migraine,Not Intractable w/o Status Migrainosis,Unspec
 ;;^UTILITY(U,$J,358.3,14237,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,14237,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,14238,0)
 ;;=G12.20^^83^822^93
 ;;^UTILITY(U,$J,358.3,14238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14238,1,3,0)
 ;;=3^Motor Neuron Disease,Unspec
 ;;^UTILITY(U,$J,358.3,14238,1,4,0)
 ;;=4^G12.20
 ;;^UTILITY(U,$J,358.3,14238,2)
 ;;=^5003761
 ;;^UTILITY(U,$J,358.3,14239,0)
 ;;=G25.70^^83^822^94
 ;;^UTILITY(U,$J,358.3,14239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14239,1,3,0)
 ;;=3^Movement Disorder,Drug-Induced,Unspec
 ;;^UTILITY(U,$J,358.3,14239,1,4,0)
 ;;=4^G25.70
 ;;^UTILITY(U,$J,358.3,14239,2)
 ;;=^5003798
 ;;^UTILITY(U,$J,358.3,14240,0)
 ;;=G35.^^83^822^95
 ;;^UTILITY(U,$J,358.3,14240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14240,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,14240,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,14240,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,14241,0)
 ;;=G25.3^^83^822^96
 ;;^UTILITY(U,$J,358.3,14241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14241,1,3,0)
 ;;=3^Myoclonus
 ;;^UTILITY(U,$J,358.3,14241,1,4,0)
 ;;=4^G25.3
 ;;^UTILITY(U,$J,358.3,14241,2)
 ;;=^80620
 ;;^UTILITY(U,$J,358.3,14242,0)
 ;;=G70.9^^83^822^97
 ;;^UTILITY(U,$J,358.3,14242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14242,1,3,0)
 ;;=3^Myoneural Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,14242,1,4,0)
 ;;=4^G70.9
 ;;^UTILITY(U,$J,358.3,14242,2)
 ;;=^5004087
 ;;^UTILITY(U,$J,358.3,14243,0)
 ;;=G31.9^^83^822^98
 ;;^UTILITY(U,$J,358.3,14243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14243,1,3,0)
 ;;=3^Nervous System Degenerative Disease,Unspec
 ;;^UTILITY(U,$J,358.3,14243,1,4,0)
 ;;=4^G31.9
 ;;^UTILITY(U,$J,358.3,14243,2)
 ;;=^5003815
 ;;^UTILITY(U,$J,358.3,14244,0)
 ;;=G50.0^^83^822^100
 ;;^UTILITY(U,$J,358.3,14244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14244,1,3,0)
 ;;=3^Neuralgia,Trigeminal
 ;;^UTILITY(U,$J,358.3,14244,1,4,0)
 ;;=4^G50.0
 ;;^UTILITY(U,$J,358.3,14244,2)
 ;;=^121978
 ;;^UTILITY(U,$J,358.3,14245,0)
 ;;=G62.81^^83^822^106
 ;;^UTILITY(U,$J,358.3,14245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14245,1,3,0)
 ;;=3^Neuropathy,Critical Illness Polyneuropathy
 ;;^UTILITY(U,$J,358.3,14245,1,4,0)
 ;;=4^G62.81
 ;;^UTILITY(U,$J,358.3,14245,2)
 ;;=^328481
 ;;^UTILITY(U,$J,358.3,14246,0)
 ;;=G62.1^^83^822^101
 ;;^UTILITY(U,$J,358.3,14246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14246,1,3,0)
 ;;=3^Neuropathy,Alcoholic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,14246,1,4,0)
 ;;=4^G62.1
 ;;^UTILITY(U,$J,358.3,14246,2)
 ;;=^5004076
 ;;^UTILITY(U,$J,358.3,14247,0)
 ;;=G51.0^^83^822^102
 ;;^UTILITY(U,$J,358.3,14247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14247,1,3,0)
 ;;=3^Neuropathy,Bell's Palsy
 ;;^UTILITY(U,$J,358.3,14247,1,4,0)
 ;;=4^G51.0
 ;;^UTILITY(U,$J,358.3,14247,2)
 ;;=^13238
